There's a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Sigyn Therapeutics (SIGY – Research Report) with bullish sentiments. Sigyn Therapeutics (SIGY) Fundamental Research analyst Siddharth Rajeev reiterated a Buy rating on Sigyn Therapeutics on February 24 and set a price target of $0.93. The company's shares closed last Friday at $0.25, close to its 52-week low of $0.17. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-sigyn-therapeutics-sigy?utm_source=advfn.com&utm_medium=referral